Results 131 to 140 of about 782 (172)

Monotherapy and combination therapy using antibody‑drug conjugates for platinum‑resistant ovarian cancer. [PDF]

Oncol Rep
Shen K, Yuan S, Su N, Tang F, Rehim S, Wang H, Guo H, Zhang Y, Wu Y, Wang H.   +9 more
europepmc   +1 more source

A review of recent advances on single use of antibody-drug conjugates or combination with tumor immunology therapy for gynecologic cancer. [PDF]

Front Pharmacol, 2022
Wang AJ, Gao Y, Shi YY, Dai MY, Cai HB.
europepmc   +1 more source

Effect of Inorganic Phosphorus Manipulation on the Growth and Progression of Prostate Cancer Cells In Vitro. [PDF]

Int J Mol Sci
Kourie CM, Ghamlouche F, Hachem S, Yehya A, Jaafar L, El-Mallah C, Abou-Kheir W, Obeid O.   +7 more
europepmc   +1 more source

Maternal excess dietary phosphate intake in the periconceptional period is a potential risk for mineral disorders in offspring mice. [PDF]

Sci Rep
Hayashi-Suzuki M, Fukuda-Tatano S, Kishimoto-Ogata M, Ehara-Kawagishi M, Ohminami H, Masuda M, Taketani Y.   +6 more
europepmc   +1 more source

Management of Advanced Ovarian Cancer: Current Clinical Practice and Future Perspectives. [PDF]

Biomedicines
Papageorgiou D, Liouta G, Pliakou E, Zachariou E, Sapantzoglou I, Prokopakis I, Kontomanolis EN.   +6 more
europepmc   +1 more source

Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers. [PDF]

Clin Med Insights Oncol
Khadela A, Megha K, Shah VB, Soni S, Shah AC, Mistry H, Bhatt S, Merja M.   +7 more
europepmc   +1 more source

Approach to a Child with Hypophosphatemia. [PDF]

Biomolecules
Antonowicz A, Lipiński P, Popow M, Skrzypczyk P.   +3 more
europepmc   +1 more source

Toxicity and efficacy of antibody-drug conjugates in advanced solid tumors: a retrospective single-center analysis of clinical trials. [PDF]

ESMO Open
Woodford R, Almarzouq H, Beygozlu N, Cammarota A, Joshi K, Grochot R, Williams A, Swanton C, Fontana E.   +8 more
europepmc   +1 more source

836P Safety and efficacy of XMT-1536 in ovarian cancer: A subgroup analysis from the phase I expansion study of XMT-1536, a NaPi2b antibody-drug conjugate

, 2020
Erika Hamilton, Minal Barve, Anthony W. Tolcher, Joseph Buscema, Kyriakos P. Papadopoulos, Corrine Zarwan, Charles Anderson, Deborah B. Doroshow, Dee Dee Wang, D. Huebner, Valerie M. Jansen, Donna Jarlenski, Rebecca Mosher, Jonathan L. Kaufman, Kathleen N. Moore, Debra L. Richardson   +15 more
openalex   +1 more source

Targeted radiopharmaceuticals: an underexplored strategy for ovarian cancer. [PDF]

Theranostics
Crabbé M, Opsomer T, Vermeulen K, Ooms M, Segers C.   +4 more
europepmc   +1 more source